Nuvasive Inc (NUVA) Return on Assets ROA from the second quarter of 2023 to second quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Nuvasive Inc  (NASDAQ: NUVA)


Nuvasive Inc's ROA from the second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Nuvasive Inc's ROA in the second quarter of 2023?
Nuvasive Inc achieved a return on average assets (ROA) of 1.31 % in its second quarter of 2023, this is above NUVA's average return on assets of 0.8%.
Nuvasive Incs assets during the 12 months ending in the second quarter of 2023 are valued at $2 billion

ROA has improved compared to 0.92% in the first quarter of 2023, due to net income growth.

However, within the Healthcare sector 194 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2023 quarter, so far to 2265, from total ROA ranking in the first quarter of 2023 at 2593.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Total Assets Change -3.83 % 0.38 % 3.32 % 1.93 % 1.29 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 28 20 40 -20 -40
Return On Assets (TTM) 1.31 % 0.92 % 1.85 % -0.94 % -1.86 %
NUVA's Total Ranking # 2265 # 2593 # 2466 # 3253 # 3503
Total Assets (TTM) in million 2,091 2,169 2,226 2,175 2,174
Seq. Total Assets Change -3.58 % -2.56 % 2.32 % 0.04 % 0.63 %
Seq. Net Income Change - - - - -

NUVA's 5 Years Annual ROA >> Back to NUVA Management Effectiveness >> Compare NUVA ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 63
Sector # 195
Overall # 2231

Return On Assets Statistics
High Average Low
8.53 %
0.8 %
-6.58 %
(Jun 30 2011)   (Jun 30 2012)





Financial Statements
Nuvasive Inc's Assets $ 2,091 million NUVA's Balance sheet
Nuvasive Inc's Income $ 7 million Quarterly NUVA's Income Statement
NUVA's Income by Division See NUVA's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018
Y / Y Total Assets Change 3.32 % -20.01 % 42.85 % 10.39 % 4.2 %
Total Assets in million 2,226 2,154 2,693 1,885 1,708
Y / Y Net Income Change - - - 422.75 % -84.64 %
Net Income in million 40 -64 -37 65 12
Annual Return On Assets 1.82 % -2.98 % -1.38 % 3.46 % 0.73 %

NUVA's 5 Years Annual ROA >> Back to NUVA Management Effectiveness >> Compare NUVA ROA to its Competitors



Comment on NUVA's ROA in the fiscal year ending 2022
In the fiscal year 2022 ROA improved to 1.82 % compared to prior year, due to annual net income growth of % to $40.41 million, while value of Nuvasive Inc's overall assets grew just by 3.32 % to $2,225.66 million, compared to $2,225.66 a year before.


More Return On Assets Ratios
NUVA's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
NUVA's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for NUVA's Competitors
Subscribers only: Roa for Nuvasive Inc's Suppliers
Subscribers only: Return On Assets for NUVA's Customers

You may also want to know
NUVA's Roi NUVA's Inventory Turnover Ratio NUVA's Growth Rates NUVA's Dividend Comparisons
NUVA's Profitability Ratios NUVA's Asset Turnover Ratio NUVA's Dividend Growth
NUVA's Roe NUVA's Valuation Ratios NUVA's Financial Strength Ratios NUVA's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2023, within Healthcare Sector ROA
Privia Health Group Inc   3.53 %
Aspire Biopharma Holdings Inc   3.47 %
Integra Lifesciences Holdings Corp  3.45 %
Cryo cell International Inc   3.44 %
Phibro Animal Health Corporation  3.42 %
Hh and l Acquisition Co   3.40 %
Envista Holdings Corporation  3.31 %
Select Medical Holdings Corp  3.30 %
Ligand Pharmaceuticals Incorporated  3.21 %
Avantor Inc   3.19 %
Docgo Inc   3.17 %
Becton Dickinson And Company  3.12 %
Eagle Pharmaceuticals inc   2.97 %
Merck and Co Inc   2.91 %
Boston Scientific Corporation  2.79 %
Insulet Corporation  2.77 %
Rapid Therapeutic Science Laboratories Inc   2.75 %
Royalty Pharma Plc  2.74 %
Bioplus Acquisition Corp   2.71 %
Nature s Sunshine Products inc   2.69 %
Supernus Pharmaceuticals inc   2.68 %
Skinhealth Systems Inc   2.67 %
The Pennant Group Inc   2.67 %
Macrogenics Inc   2.65 %
Lantheus Holdings Inc   2.62 %
Integer Holdings Corporation  2.53 %
Longduoduo Co Ltd  2.46 %
Zimmer Biomet Holdings Inc   2.39 %
The Cooper Companies Inc   2.38 %
Vanda Pharmaceuticals Inc   2.34 %

Date modified: 2026-09-12T06:12:52+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.